January 2025 in “Clinical and Experimental Optometry” This study investigates the relationship between male androgenetic alopecia and dry eye, as well as meibomian gland function, by evaluating 80 eyes from 80 patients, split evenly between those with androgenetic alopecia and healthy controls. Results indicate that patients with androgenetic alopecia have significantly lower Schirmer I test scores and tear film break-up time (TBUT), and higher Ocular Surface Disease Index and Oxford scale scores, suggesting more severe dry eye symptoms. Additionally, meibomian gland dysfunction was more pronounced in the androgenetic alopecia group, with higher total, upper, and lower gland scores. These findings suggest a potential association between androgenetic alopecia and both dry eye and meibomian gland dysfunction, highlighting the need for careful monitoring of these conditions in affected individuals.
[object Object] 2 citations,
September 2023 in “Curēus” Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.
April 2024 in “Pharmaceuticals” Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.
July 2021 in “International Ophthalmology” Female hair loss patients more likely to have dry eye and gland issues.
July 2015 in “British Journal of Dermatology” Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.